We are live on ! Find out more
CAG

Csenge Advisory Group Portfolio holdings

AUM $2.18B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
+1.81%
1 Year Est. Return
+16.73%
3 Year Est. Return
+51.88%
5 Year Est. Return
+54.25%
10 Year Est. Return
AUM
$2.21B
AUM Growth
+$116M
Cap. Flow
+$90.3M
Cap. Flow %
4.08%
Top 10 Hldgs %
33.51%
Holding
772
New
90
Increased
341
Reduced
259
Closed
60

Sector Composition

Rank Sector Weight
1 Technology 6.91%
2 Financials 3.54%
3 Consumer Discretionary 2.98%
4 Healthcare 2.6%
5 Industrials 2.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGIB icon
551
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$317K 0.01%
+5,878
New +$318K
ARCC icon
552
Ares Capital
ARCC
$13.6B
$316K 0.01%
15,627
CWEB icon
553
Direxion Daily CSI China Internet Index Bull 2X ETF
CWEB
$228M
$316K 0.01%
+7,868
New +$378K
LRCX icon
554
Lam Research
LRCX
$365B
$315K 0.01%
1,840
+243
+15% +$37.8K
MAR icon
555
Marriott International
MAR
$101B
$314K 0.01%
1,013
+5
+0.5% +$1.43K
VPL icon
556
Vanguard FTSE Pacific ETF
VPL
$8.06B
$314K 0.01%
3,470
-255
-7% -$23.1K
NXPI icon
557
NXP Semiconductors
NXPI
$67.6B
$313K 0.01%
1,444
-355
-20% -$76.1K
ABEV icon
558
Ambev
ABEV
$47.4B
$311K 0.01%
+125,924
New +$300K
SYSB
559
iShares Systematic Bond ETF
SYSB
$1.16B
$310K 0.01%
+3,452
New +$311K
RKLB icon
560
Rocket Lab Corp
RKLB
$41.8B
$310K 0.01%
+4,437
New +$254K
UTES icon
561
Virtus Reaves Utilities ETF
UTES
$1.38B
$309K 0.01%
+3,908
New +$322K
AKRE
562
Akre Focus ETF
AKRE
$5.22B
$308K 0.01%
+4,709
New +$305K
COKE icon
563
Coca-Cola Consolidated
COKE
$12.4B
$307K 0.01%
2,000
ICVT icon
564
iShares Convertible Bond ETF
ICVT
$7.21B
$302K 0.01%
3,071
+131
+4% +$13.2K
JEPQ icon
565
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
$39B
$301K 0.01%
5,176
+220
+4% +$12.8K
MDLZ icon
566
Mondelez International
MDLZ
$77.9B
$300K 0.01%
5,571
-14
-0.3% -$806
AVXC icon
567
Avantis Emerging Markets ex-China Equity ETF
AVXC
$388M
$299K 0.01%
4,687
+423
+10% +$26.3K
RXL icon
568
ProShares Ultra Health Care
RXL
$85.3M
$297K 0.01%
+5,734
New +$280K
DIVB icon
569
iShares Core Dividend ETF
DIVB
$1.67B
$295K 0.01%
5,547
+317
+6% +$16.6K
NEM icon
570
Newmont
NEM
$98.5B
$294K 0.01%
+2,948
New +$266K
PFG icon
571
Principal Financial Group
PFG
$24B
$294K 0.01%
3,332
-19
-0.6% -$1.6K
TGT icon
572
Target
TGT
$63.7B
$293K 0.01%
2,994
+760
+34% +$70K
CMCSA icon
573
Comcast
CMCSA
$80.9B
$292K 0.01%
9,774
-1,979
-17% -$56.5K
EMGF icon
574
iShares Emerging Markets Equity Factor ETF
EMGF
$1.81B
$288K 0.01%
4,982
+378
+8% +$21.8K
VV icon
575
Vanguard Large-Cap ETF
VV
$51.9B
$288K 0.01%
914
+168
+23% +$52.5K

Similar funds

Csenge Advisory Group's Q4 2025 Portfolio in Review

As of Q4 2025, Csenge Advisory Group held 772 positions worth $2.21B, up 5.6% from $2.09B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Csenge Advisory Group deployed $90.3M of net new capital in Q4 2025, opening 90 new positions and adding to 341 existing holdings. Its largest new stake was Franklin FTSE Asia ex Japan ETF: 244,991 shares worth $7.26M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was ProShares Short High Yield, an estimated $19.5M trimmed.

  • Csenge Advisory Group's largest Q4 2025 buy was Franklin FTSE Asia ex Japan ETF: 244,991 shares worth $7.26M.
  • Csenge Advisory Group added most to State Street Health Care Select Sector SPDR ETF in Q4 2025, an estimated $8.19M increase.
  • Csenge Advisory Group's biggest Q4 2025 reduction was ProShares Short High Yield, cutting an estimated $19.5M.
  • Csenge Advisory Group fully exited State Street SPDR S&P Insurance ETF in Q4 2025, selling an estimated $9.32M.
  • Csenge Advisory Group's ten largest holdings make up 34% of its $2.21B portfolio in Q4 2025.
  • Csenge Advisory Group opened 90 new positions and closed 60 in Q4 2025.
  • Csenge Advisory Group's portfolio value rose 5.6% quarter-over-quarter to $2.21B.

Based on Csenge Advisory Group's 13F filing for Q4 2025, filed 6 Feb 2026.